Skip to main content
logo

Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Market Cap587.96B +36.4%
Revenue (ttm)290.49B +8.7%
Net Income56.43B +38.8%
EPS15.45 +38.8%
Shares Out 3.65B
PE Ratio10.42
Forward PEn/a
Dividend16.60 (10.31%)
Ex-Dividend DateJul 17, 2026
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. EarningsNov 4, 2026

About UGSE:QCIL

Quality Chemical Industries Limited engages in the manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers rabeprazole for the treatment ... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In fiscal year 2026, UGSE:QCIL's revenue was 290.49 billion, an increase of 8.75% compared to the previous year's 267.13 billion. Earnings were 56.43 billion, an increase of 38.81%.

Financial Statements